LMAT Lemaitre Vascular Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LMAT

Price (delayed)

$77.74

Market cap

$1.78B

P/E Ratio

27.86

Dividend/share

$0.95

EPS

$2.79

Enterprise value

$1.94B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 85

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures ...

Highlights
The P/E is 34% less than the 5-year quarterly average of 43.1 and 15% less than the last 4 quarters average of 33.5
The equity has grown by 14% YoY and by 2.8% from the previous quarter
LMAT's net income is up by 19% year-on-year but it is down by 3.6% since the previous quarter
The EPS has grown by 18% YoY but it has contracted by 3.8% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.lemaitre.com
Peers: ANGO BSX EW BAX

Key stats

What are the main financial stats of LMAT

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
-1.95%
1 week
-6.89%
1 month
-6.24%
1 year
-13.59%
YTD
-4.14%
QTD
-5.87%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$269.36M
Gross profit
$194.06M
Operating income
$74.7M
Net income
$63.34M
Gross margin
72%
Net margin
23.5%
The operating income has grown by 21% YoY but it has contracted by 3.4% from the previous quarter
LMAT's net income is up by 19% year-on-year but it is down by 3.6% since the previous quarter
The company's gross profit rose by 14% YoY
Lemaitre Vascular's revenue has increased by 12% YoY and by 2.6% from the previous quarter

Price vs fundamentals

How does LMAT's price correlate with its fundamentals

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
LMAT P/E details
P/E
27.86
P/B
4.11
P/S
6.6
EV/EBIT
22.29
EV/EBITDA
19.83
EV/Sales
7.2
The P/E is 34% less than the 5-year quarterly average of 43.1 and 15% less than the last 4 quarters average of 33.5
The EPS has grown by 18% YoY but it has contracted by 3.8% from the previous quarter
LMAT's price to book (P/B) is 18% lower than its last 4 quarters average of 5.1 and 14% lower than its 5-year quarterly average of 4.9
The equity has grown by 14% YoY and by 2.8% from the previous quarter
The P/S is 17% below the last 4 quarters average of 8.1 and 13% below the 5-year quarterly average of 7.7
Lemaitre Vascular's revenue has increased by 12% YoY and by 2.6% from the previous quarter

Efficiency

How efficient is Lemaitre Vascular business performance
Lemaitre Vascular's return on assets has increased by 8% YoY but it has decreased by 6% QoQ
LMAT's ROIC is up by 8% year-on-year but it is down by 5% since the previous quarter
The ROE has contracted by 7% from the previous quarter but it has grown by 2% YoY
The ROS has grown by 7% YoY but it has contracted by 6% from the previous quarter

Dividends

What is LMAT's dividend history
Dividend details
DPS
$0.95
Dividend yield
1.22%
Payout ratio
34.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lemaitre Vascular financials performed over time
The company's total assets is 193% higher than its total liabilities
LMAT's quick ratio is down by 11% QoQ but it is up by 9% YoY
The company's total assets rose by 10% YoY and by 2.4% QoQ
The company's debt is 56% lower than its equity
The equity has grown by 14% YoY and by 2.8% from the previous quarter
Lemaitre Vascular's debt to equity has decreased by 10% YoY and by 2.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.